Axogen, Inc.
AXGN · XNASCIK 805928fmd_0HKPK9KPBKV2J48RF2X7B98P2TManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2026, 66 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 41 | 60 | 84 | 107 | 112 | 127 | 139 | 159 | 187 | 225 |
| Cost of revenue | 6 | 9 | 13 | 17 | 22 | 23 | 30 | 37 | 45 | 58 |
| Gross profit | 35 | 51 | 71 | 89 | 91 | 104 | 109 | 122 | 142 | 167 |
| Research and development | 4 | 7 | 12 | 18 | 18 | 24 | 26 | 27 | 28 | 33 |
| Selling, general and administrative | 39 | 52 | 80 | 103 | 96 | 106 | 113 | 116 | 117 | 142 |
| Operating income | (8) | (8) | (21) | (31) | (23) | (25) | (30) | (21) | (3) | (8) |
| Interest expense | 5 | 2 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 8 |
| Other non-operating income (expense) | (6) | (2) | (2) | 2 | (1) | (2) | 1 | (0) | (7) | (8) |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | – | – | – | – | – |
| Net income | (14) | (10) | (22) | (29) | (24) | (27) | (29) | (22) | (10) | (16) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |